BECTON DICKINSON & CO : Change in Directors or Principal Officers (form 8-K)

Published: 2021-10-22 06:56:08 ET BDX

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 21, 2021, Carrie L. Byington, M.D. was elected to the Board of Directors of Becton, Dickinson and Company ("BD"). Upon joining BD's Board of Directors, Dr. Byington will serve as a member of both the Audit Committee and the Quality and Regulatory Committee of the Board. BD's Board of Directors has determined that Dr. Byington is independent under the rules of the New York Stock Exchange and the independence guidelines contained in BD's Statement of Corporate Governance Principles. Information regarding the compensation of the non-management members of BD's Board of Directors is included under the caption "Non-Management Directors' Compensation" in BD's proxy statement relating to its 2021 Annual Meeting of Shareholders. In connection with her appointment, Dr. Byington will receive restricted stock units valued at $54,969, representing a prorated grant from the effective date of her election to BD's 2022 Annual Meeting of Shareholders.

--------------------------------------------------------------------------------